Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients

Nephrology Dialysis Transplantation

Volumn 30, Issue 1, 2015, Pages 54-61

  Ethgen, Olivier ^a   Schneider, Antoine G ^b   Bagshaw, Sean M ^c   Bellomo, Rinaldo ^d   Kellum, John A ^e  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF ALBERTA   (Canada)

^d AUSTIN HOSPITAL   (Australia)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

acute kidney injury; dialysis dependence; economic analysis

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; ECONOMICS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; INTERMITTENT RENAL REPLACEMENT THERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; QUALITY ADJUSTED LIFE YEAR; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK; SURVIVAL; ACUTE KIDNEY INJURY; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; DECISION MAKING; HEMODIALYSIS; MORTALITY; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DECISION MAKING; HUMANS; INTENSIVE CARE UNITS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE;

EID: 84922434303     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu314     Document Type: Article

References (24)

1. Rabindranath KS, Adams J, MacLeod AM et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; Issue 3. Art. No. CD003773. DOI: 10.1002/14651858.CD003773.pub3
2. Bagshaw SM, Berthiaume LR, Delaney A et al. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-Analysis. Crit Care Med 2008; 36: 610-617
3. Pannu N, Klarenbach S, Wiebe N et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008; 299: 793-805
4. Van Berendoncks AM, Elseviers MM, Lins RL. Outcome of acute kidney injury with different treatment options: long-term follow-up. Clin J Am Soc Nephrol 2010; 5: 1755-1762
5. Medicare Payment Advisory Commission, June 2012. http://www.medpac .gov/documents/reports/jun12-entirereport.pdf?sfvrsn=0 (25 April 2014, date last accessed)
6. Schneider AG, Bellomo R, Bagshaw SM et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-Analysis. Intensive Care Med 2013; 39: 987-997
7. Wald R, Shariff SZ, Adhikari NK et al. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Critic Care Med 2014; 42: 868-877
8. Husereau D, Drummond M, Petrou S et al. Consolidated health economics evaluation reporting standards (CHEERS) statement. BMJ 2013; 346: f1049
9. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Dec Making 1993; 13: 322-338
10. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13: 397-409
11. The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Eng J Med 2008; 359: 7-20
12. The RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N Eng J Med 2009; 361: 1627-1638
13. Uchino S, Bellomo R, Kellum JA et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artificial Organs 2007; 30: 281-292
14. Manns B, Doig CJ, Lee H et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Critic Care Med 2003; 31: 449-455
15. Srisawat N, Lawsin L, Uchino S et al. Cost of acute renal replacement therapy in the intensive care unit: results from the beginning and ending supportive therapy for the kidney (BEST kidney) study. Critic Care 2010; 14: R46
16. De Smedt DM, Elseviers MM, Lins RL et al. Economic evaluation of different treatment modalities in acute kidney injury. Nephrol Dial Transplant 2012; 27: 4095-4101
17. Klarenbach S, Manns B, Pannu N et al. Economic evaluation of continuous real replacement therapy in acute renal failure. Int J Tech Ass Health Care 2009; 23: 331-338
18. US Bureau of Labor Statistics. Consumer price index medical care services. http://www.bls.gov/data/(5 May 2014, date last accessed)
19. Johansen KL, Smith MW, Unruh ML et al. Predictors of health utility among 60-days survivors of acute kidney injury in the Veterans Affairs/National Institute of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol 2010; 5: 1366-1372
20. James MT, Tonelli M. Financial aspects of renal replacement therapy in acute kidney injury. Semin Dial 2011; 24: 215-219
21. Icks A, Haastert B, Gandjour A et al. Costs of dialysis-A regional population-based analysis. Nephrol Dial Transplant 2010; 25: 1647-1652
22. Kidney Health Australia, 2014. http://www.kidney.org.au/Kidneydisease/FastFactsonCKD/tabid/589/Default.aspx (14 January 2014, date last accessed)
23. Palevsky PM, OConnor TZ, Chertow GM et al. Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Critic Care 2009; 13: 310
24. Bellomo R, Schneider AG. The real cost of conventional dialysis in critically ill patients. Critic Care Med 2014; 42: 990-991